NRx Pharmaceuticals Inc.
4.47
-0.63 (-12.35%)
At close: Jan 15, 2025, 12:51 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
PE Ratio -1.16 -20.72 -31.27 -677.26 132.06 1.38K -83.27
PS Ratio n/a n/a n/a n/a n/a n/a n/a
PB Ratio -2.97 98.53 107.79 -191.04 1.83 1.31 0.13
P/FCF Ratio -1.61 -18.36 -59.47 -3.69K -68.04 -192.39 -64.4
P/OCF Ratio -1.61 -18.36 -59.48 -3.69K -68.04 -192.39 -64.4
OCF/S Ratio n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio -0.78 1.42 0.02 -0.02 0.07 0.01 n/a
Quick Ratio 0.36 1.56 2.74 0.06 0.11 0.05 5.76
Current Ratio 0.36 1.56 2.74 0.06 0.11 0.05 5.76
Asset Turnover n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -229.89 n/a -6.43K -917.63 n/a n/a n/a
Return on Equity (ROE) 2.57 -4.76 -3.45 0.28 0.01 0.00 -0.00
Return on Assets (ROA) -4.12 -1.36 -2.19 -4.2 0.01 0.00 -0.00
Return on Capital (ROIC) 2.35 -4.81 -5.57 1.19 -0.00 -0.01 n/a
Dividend Yield n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a n/a n/a n/a n/a